Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT07042126
Recruiting
Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis
Phase 3 · China · 3 sites
Registry update: 18 Nov 2025
NCT07046429
Recruiting
Affect of Melatonin on Sleep and Cognition in Cirrhosis
Not applicable · United States · 1 site
Registry update: 29 Jul 2026
NCT06615596
Recruiting
Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation
Early phase 1 · China, United States · 12 sites
Registry update: 4 Jun 2026
NCT06825559
Recruiting
Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Phase 1 · United States · 1 site
Registry update: 14 Sept 2026
NCT07009132
Recruiting
Cholate Clearance in Fontan and Heart Failure
Not applicable · United States · 1 site
Registry update: 17 Sept 2026
NCT06623994
Recruiting
Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)
Not applicable · Kenya · 1 site
Registry update: 29 Jul 2026
NCT07126236
Recruiting
Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell Lymphoma
Phase 2 · Spain · 19 sites
Registry update: 29 Sept 2026
NCT06967493
Recruiting
Effects of Amazonian Dance on Motor and Non-motor Symptoms of People With Parkinson's: Study Protocol
Not applicable · Brazil · 2 sites
Registry update: 13 May 2025
NCT06586619
Recruiting
A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
Not applicable · United States · 1 site
Registry update: 16 Sept 2026
NCT07151677
Recruiting
Brain Stimulation Effects on Post-Stroke Fatigue and Aphasia
Not applicable · United States · 2 sites
Registry update: 30 Sept 2026
NCT07092670
Recruiting
MELAFERT: Impact of Adjuvant Therapy on FERTility in Patients With Resected MELAnoma at High Risk of Relapse.
Not applicable · Italy · 10 sites
Registry update: 5 Sept 2025
NCT07621419
Recruiting
Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin
Not applicable · Argentina · 2 sites
Registry update: 2 Jun 2026
NCT07391839
Recruiting
MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.
Phase 1 · China · 8 sites
Registry update: 6 Feb 2026
NCT07109531
Recruiting
ASKC202 Combined With Limertinib Versus Platinum-based Chemotherapy in Treatment of Locally Advanced or Metastatic NSCLC With MET Amplification/Overexpression After Failure of EGFR-TKI Therapy
Phase 3 · China · 1 site
Registry update: 19 Aug 2026
NCT07145918
Recruiting
A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia
Phase 2 · United States · 7 sites
Registry update: 15 Sept 2026
NCT07182981
Recruiting
Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance
Not applicable · 1 site
Registry update: 19 Sept 2025
NCT07755020
Recruiting
Nitride-Based Raman Biochip for Lung Cancer Diagnosis and Monitoring
Not applicable · Taiwan · 1 site
Registry update: 10 Aug 2026
NCT07202364
Recruiting
A Study of YL202 in Patients With Advanced Solid Tumors
Phase 2 · China · 1 site
Registry update: 14 Oct 2026
NCT07104721
Recruiting
A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
Phase 1 · China · 1 site
Registry update: 21 Oct 2026
NCT06790784
Recruiting
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
Phase 3 · United States · 34 sites
Registry update: 18 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.